Barinthus Biotherapeutics plc (BRNS) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$0.62
-2.13%
Mkt Cap $22.95M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | — | — | — | -$0.40 | -$0.27 | +32.50% | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | -$0.45 | -$0.36 | +20.00% | — | — |
| Q3 2025 Aug 7, 2025 | — | — | — | -$0.29 | -$0.52 | -79.31% | — | — |
| Q2 2025 May 7, 2025 | — | — | — | -$0.34 | -$0.49 | -44.12% | — | — |
| Q1 2025 Mar 20, 2025 | — | -$9.17M | — | -$0.50 | -$0.51 | -2.00% | — | — |
| Q4 2024 Nov 6, 2024 | — | $14.97M | — | -$0.45 | -$0.21 | +53.33% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.42 | -$0.43 | -2.38% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$0.64 | -$0.40 | +37.50% | — | — |
| Q1 2024 Mar 20, 2024 | $130.00K | $5.37M | +4030.21% | -$0.55 | -$0.45 | +18.18% | — | — |
| Q4 2023 Nov 9, 2023 | $130.00K | — | — | -$0.62 | -$0.37 | +40.32% | — | — |
| Q3 2023 Aug 10, 2023 | $704.25K | $334.00K | -52.57% | -$0.59 | -$0.62 | -5.08% | — | — |
| Q1 2023 Mar 31, 2023 | $1.40M | $468.00K | -66.57% | -$0.50 | -$0.48 | +4.79% | — | — |
| Q4 2022 Dec 31, 2022 | $3.31M | $6.46M | +94.99% | -$0.43 | -$0.56 | -32.27% | — | — |
| Q3 2022 Sep 30, 2022 | $7.80M | $6.17M | -20.96% | -$0.38 | $0.22 | +157.22% | — | — |
| Q2 2022 Jun 30, 2022 | $3.71M | $17.06M | +360.54% | -$0.32 | $0.41 | +227.18% | — | — |
| Q1 2022 Mar 31, 2022 | — | $15.02M | — | — | $0.07 | — | — | — |
| Q4 2021 Dec 31, 2021 | $3.71M | $268.00K | -92.77% | -$0.31 | $0.07 | +121.94% | — | — |
| Q3 2021 Sep 30, 2021 | — | $19.00K | — | — | -$0.13 | — | — | — |
| Q2 2021 Jun 30, 2021 | $100.00K | $35.00K | -65.00% | -$0.38 | -$0.64 | -69.83% | — | — |
| Q1 2021 Mar 31, 2021 | — | $215.00K | — | — | -$0.45 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | $4.82M | — | — | -$92.90 | — | — | — |
| Q3 2020 Sep 30, 2020 | — | $3.25M | — | — | $3.32 | — | — | — |
| Q2 2020 Jun 30, 2020 | — | $511.00K | — | — | -$75.31 | — | — | — |
| Q1 2020 Mar 31, 2020 | — | $705.00K | — | — | -$80.20 | — | — | — |